Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines
Top Cited Papers
Open Access
- 1 June 2020
- journal article
- review article
- Published by Elsevier in Integrative Medicine Research
- Vol. 9 (2) , 100407
Abstract
No abstract availableKeywords
Funding Information
- Korea Institute of Oriental Medicine (KSN2013210)
This publication has 8 references indexed in Scilit:
- Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention ProgramsChinese Journal of Integrative Medicine, 2020
- Magnoflorine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Suppressing NF-κB and MAPK ActivationFrontiers in Pharmacology, 2018
- Protective Effects of Platycodin D on Lipopolysaccharide-Induced Acute Lung Injury by Activating LXRα–ABCA1 Signaling PathwayFrontiers in Immunology, 2017
- Pharmacokinetics of aconitine-type alkaloids after oral administration of Fuzi (Aconiti Lateralis Radix Praeparata) in rats with chronic heart failure by microdialysis and ultra-high performance liquid chromatography–tandem mass spectrometryJournal of Ethnopharmacology, 2015
- [Study on in vitro anti-inflammatory activity of total flavonoids from Glycyrrhizae Radix et Rhizoma and its ingredients].2013
- Traditional Chinese herbal medicine as a source of molecules with antiviral activityAntiviral Research, 2013
- Pharmacological effects of Chinese herb aconite (Fuzi) on cardiovascular systemJournal of Traditional Chinese Medicine, 2012
- In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compoundsJournal of Clinical Virology, 2004